2p15p16.1 microdeletion syndrome

2p15p16.1 microdeletion syndrome (also known as 2p15-16.1 microdeletion syndrome or chromosome 2p15-p16.1 deletion syndrome) is a rare chromosomal disorder caused by a small deletion (microdeletion) on the short arm of chromosome 2, in the region spanning bands p15 to p16.1. This condition affects multiple body systems and is characterized by intellectual disability, developmental delay, and distinctive facial features. The facial features commonly include microcephaly (small head), a high and broad forehead, telecanthus or widely spaced eyes, a short philtrum, a thin upper lip, and a broad or depressed nasal bridge. Many affected individuals also have feeding difficulties in infancy, hypotonia (low muscle tone), and short stature. Additional features may include structural brain abnormalities (such as cortical malformations or optic nerve hypoplasia), skeletal anomalies including camptodactyly (permanently bent fingers), kidney malformations, and visual or hearing impairments. Behavioral features such as autism spectrum disorder have also been reported in some patients. The severity of symptoms can vary depending on the size and exact location of the deletion. Most cases reported in the literature have been de novo (new) deletions, meaning they arise spontaneously and are not inherited from a parent. There is currently no cure or targeted therapy for 2p15p16.1 microdeletion syndrome. Management is supportive and symptom-based, involving a multidisciplinary team that may include developmental pediatricians, neurologists, speech and occupational therapists, and other specialists. Early intervention programs focusing on speech, motor, and cognitive development are recommended to optimize outcomes. Regular monitoring for associated complications, including vision, hearing, and renal abnormalities, is important for comprehensive care.

Common questions about 2p15p16.1 microdeletion syndrome